HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice.

AbstractBACKGROUND & AIMS:
High mobility group box 1 (HMGB1) is an abundant protein that regulates chromosome architecture and also functions as a damage-associated molecular pattern molecule. Little is known about its intracellular roles in response to tissue injury or during subsequent local and systemic inflammatory responses. We investigated the function of Hmgb1 in mice after induction of acute pancreatitis.
METHODS:
We utilized a Cre/LoxP system to create mice with pancreas-specific disruption in Hmbg1 (Pdx1-Cre; HMGB1(flox/flox) mice). Acute pancreatitis was induced in these mice (HMGB1(flox/flox) mice served as controls) after injection of l-arginine or cerulein. Pancreatic tissues and acinar cells were collected and analyzed by histologic, immunoblot, and immunohistochemical analyses.
RESULTS:
After injection of l-arginine or cerulein, Pdx1-Cre; HMGB1(flox/flox) mice developed acute pancreatitis more rapidly than controls, with increased mortality. Pancreatic tissues of these mice also had higher levels of serum amylase, acinar cell death, leukocyte infiltration, and interstitial edema than controls. Pancreatic tissues and acinar cells collected from the Pdx1-Cre; HMGB1(flox/flox) mice after l-arginine or cerulein injection demonstrated nuclear catastrophe with greater nucleosome release when compared with controls, along with increased phosphorylation/activation of RELA nuclear factor κB, degradation of inhibitor of κB, and phosphorylation of mitogen-activated protein kinase. Inhibitors of reactive oxygen species (N-acetyl-l-cysteine) blocked l-arginine-induced DNA damage, necrosis, apoptosis, release of nucleosomes, and activation of nuclear factor κB in pancreatic tissues and acinar cells from Pdx1-Cre; HMGB1(flox/flox) and control mice. Exogenous genomic DNA and recombinant histone H3 proteins significantly induced release of HMGB1 from mouse macrophages; administration of antibodies against H3 to mice reduced serum levels of HMGB1 and increased survival after l-arginine injection.
CONCLUSIONS:
In 2 mouse models of acute pancreatitis, intracellular HMGB1 appeared to prevent nuclear catastrophe and release of inflammatory nucleosomes to block inflammation. These findings indicate a role for the innate immune response in tissue damage.
AuthorsRui Kang, Qiuhong Zhang, Wen Hou, Zhenwen Yan, Ruochan Chen, Jillian Bonaroti, Preeti Bansal, Timothy R Billiar, Allan Tsung, Qingde Wang, David L Bartlett, David C Whitcomb, Eugene B Chang, Xiaorong Zhu, Haichao Wang, Ben Lu, Kevin J Tracey, Lizhi Cao, Xue-Gong Fan, Michael T Lotze, Herbert J Zeh 3rd, Daolin Tang
JournalGastroenterology (Gastroenterology) Vol. 146 Issue 4 Pg. 1097-107 (Apr 2014) ISSN: 1528-0012 [Electronic] United States
PMID24361123 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Hbp1 protein, mouse
  • High Mobility Group Proteins
  • Histones
  • Nucleosomes
  • Reactive Oxygen Species
  • Repressor Proteins
  • Ceruletide
  • Arginine
Topics
  • Acute Disease
  • Animals
  • Arginine
  • Cell Death
  • Ceruletide
  • DNA Damage
  • Disease Models, Animal
  • High Mobility Group Proteins (deficiency, genetics, metabolism)
  • Histones (metabolism)
  • Immunity, Innate
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nucleosomes (metabolism)
  • Oxidative Stress
  • Pancreas (immunology, metabolism, pathology)
  • Pancreatitis (chemically induced, genetics, immunology, metabolism, pathology, prevention & control)
  • Reactive Oxygen Species (metabolism)
  • Repressor Proteins (deficiency, genetics, metabolism)
  • Signal Transduction
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: